Bell Investment Advisors, Inc Recursion Pharmaceuticals, Inc. Transaction History
Bell Investment Advisors, Inc
- $574 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
372Shares Held
290MCall Options Held
7.75MPut Options Held
6.1M-
Vanguard Group Inc Valley Forge, PA39.8MShares$184 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$152 Million1.38% of portfolio
-
Baillie Gifford & CO24MShares$111 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$80 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$67.8 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $834M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...